Off on a Limb: Balancing the Decision to Amputate

Funded Research Proposal

Rising healthcare costs remain a significant challenge in the U.S., with one major contributor being the increasing incidence of amputations due to vascular diseases. The number of vascular disease-related amputations in the U.S. is projected to double by 2050, reaching an estimated 3.6 million cases. In 2023 alone, Medicare’s annual expenditure exceeded $900 billion, with $24.5 billion (~2.72%) allocated to amputation procedures and post-amputation care. Unfortunately, nearly 50% of individuals who undergo vascular disease-related amputations die within five years, a mortality rate higher than that of breast, colon, or prostate cancer.Read More